MedPath

Effect of Tab Glucitox in the management of Diabetis Mellitus

Phase 4
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/05/067188
Lead Sponsor
Kusinara Wellness Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Confirmed case of DM (NIIDDM or Type II DM)

Uncomplicated

Fasting BSL more than 125mg/dl less than or equal to 200mg/dl

PP BSL more than 200mg/dl equal to or less than 400mg/dl

HbA1c more than 7 % and 10 %

Patients with informed written consent

Exclusion Criteria

Blood sugar more than 400mg/dl,preganancy and lactating mothers,complications like hyperglycemic coma,ketoacidosis ,DM Neuropathy,retinopathy ,neuropathy ,Malignancy ,CVS disorders

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath